Skip to main content

INTEGRATED BIOPHARMA INC

For the period ended Oct 28, 2025. Filed Oct 28, 2025.

View on SEC.gov

About this filing

What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.

Oct 28, 2025 · Filed Oct 28, 2025

INBPStored price and day change unavailable
See the whole filing, with its images and exhibits
Contents

THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED

ForWithhold
The Board of Directors recommends you vote FOR
the following:
☐☐
1. To elect the Class III Director for a
THREE-YEAR TERM TO SERVE UNTIL THE 2028 ANNUAL
MEETING OF STOCKHOLDERS
Nominee
01) Eric Friedman
The Board of Directors recommends you vote for Three Years for the following:
1 Year2 Years3 YearsABSTAIN
2. A non-binding vote advisory vote on frequency of the vote
on executive compensation
The Board of Directors recommends you vote FOR the following proposals:
ForAgainstAbstain
3. A NON-BINDING VOTE ON EXECUTIVE COMPENSATION☐☐☐
4. To ratify the appointment of CBIZ CPAs P.C. as Integrated BioPharma, Inc.'s independent accountant for the fiscal
year ending June 30, 2026.
☐☐☐
NOTE: The transaction of such other business as may properly come before the Meeting or any adjournment thereof.
Please sign exactly as your name(s) appear(s) hereon. When signing as attorney, executor, administrator, or other fiduciary,
please give full title as such. Joint owners should each sign personally. All holders must sign. If a corporation or
partnership, please sign in full corporate or partnership name by authorized officer.
YesNo
Please indicate if you wish to view meeting☐☐
materials electronically via the Internet rather
than receiving a hard copy. Please note that you
will continue to receive a proxy card for voting
purposes only.
Shares
Cusip #
SEQUENCE #
Signature [PLEASE SIGN WITHIN BOX]DateSignature (Joint Owners)Date
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.